cloning and expression of major surface antigen 1 gene of toxoplasma gondii rh strain using the expression vector pvax1 in chinese hamster ovary cells

rahman abdizadeh cell and molecular research center, school of medicine, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; department of medical parasitology, school of medicine, ahvaz jundishapur university of medical sciences, ahvaz, ir iran, sharif maraghi department of medical parasitology, school of medicine, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; institute of health research, thalassemia and hemoglobinopathy research center, ahvaz jundishapur university of medical sciences, ahvaz, ir iran, ata a. ghadiri department of immunology, school of medicine, ahvaz jundishapur university of medical sciences, ahvaz, ir iran; department of immunology, school of medicine, ahvaz jundishapur university of medical sciences, ahvaz, ir iran. tel: +98-6133330144, fax: +98-6133330145, mehdi tavalla department of medical parasitology, school of medicine, ahvaz jundishapur university of medical sciences, ahvaz, ir iran, saeedeh shojaee department of medical parasitology and mycology, school of public health, tehran university of medical sciences tehran, ir iran

Abstract

background toxoplasmosis is an opportunistic protozoan infection with a high prevalence in a broad range of hosts infecting up to one-third of the world human population. toxoplasmosis leads to serious medical problems in immunocompromised individuals and fetuses and also induces abortion and mortality in domestic animals. therefore, there is a huge demand for the development of an effective vaccine. surface antigen 1 (sag1) is one of the important immunodominant surface antigens of toxoplasma gondii, which interacts with host cells and primarily involved in adhesion, invasion and stimulation of host immune response. surface antigen 1 is considered as the leading candidate for development of an effective vaccine against toxoplasmosis. objectives the purpose of this study was to clone the major surface antigen1 gene (sag1) from the genotype 1 of t. gondii, rh strain into the eukaryotic expression vector pvax1 in order to use for a dna vaccine. materials and methods genomic dna was extracted from tachyzoite of the parasite using the qiaamp dna mini kit. after designing the specific primers, sag1 gene was amplified by polymerase chain reaction (pcr). the purified pcr products were then cloned into a pprime plasmid vector. the aforementioned product was subcloned into the pvax1 eukaryotic expression vector. the recombinant pvax1-sag1 was then transfected into chinese hamster ovary (cho) cells and expression of sag1 antigen was evaluated using reverse transcriptase polymerase chain reaction (rt-pcr), immunofluorescence assay (ifa) and western blotting (wb). results: the cloning and subcloning products (pprime-sag1 and pvax1-sag1 plasmid vectors) of sag1 gene were verified and confirmed by enzyme digestion and sequencing. a 30 kda recombinant protein was expressed in cho cells as shown by ifa and wb methods. conclusions the pvax1 expression vector and cho cells are a suitable system for high-level recombinant protein production for sag1 gene from t. gondii parasites and are promising approaches for antigen preparation in vaccine development.